New York - London - Athens - Oslo

Closed-End Fund Articles


Allergan Sinks 21%: ‘Inversion’ Rules Pose Questions For Pfizer Merger

Apr 4, 2016
Click here to access Allergan Sinks 21%: 'Inversion' Rules Pose Questions For Pfizer Merger

Another stock favorite among hedge funds, Allergan (AGN), is knifing more than 20% lower in post-market trading after the U.S. Treasury Department and Internal Revenue Service announced new rules to curb corporate tax “inversions.”



provided by:

Barron's

Barron's is America's premier financial magazine. It provides in-depth analysis and commentary on the markets, updated every business day online.

Website: online.barrons.com/home-page